References
- Bok A, Noone D, Skouw-Rasmussen; EHC Think Tank. Key challenges for patient registries – A report from the 1st workshop of the EHC Think Tank Workstream on Registries. J Haem Pract 2022; 9 (1): 14–19. doi: 10.2478/jhp-2022-0002.
- Bok A, Noone D, Skouw-Rasmussen; EHC Think Tank. Key challenges for hub and spoke models of care – A report from the 1st workshop of the EHC Think Tank on Hub and Spoke Treatment Models. J Haem Pract 2022; 9 (1): 20–26. doi: 10.2478/jhp-2022-0003.
- Bok A, Noone D, Skouw-Rasmussen; EHC Think Tank. Patient agency: key questions and challenges – A report from the 1st workshop of the EHC Think Tank Workstream on Patient Agency. J Haem Pract 2022; 9 (1): 27–35. doi: 10.2478/jhp-2022-0004.
- De Santis M, Hervas C, Weinman A, Bottarelli V. Patient empowerment – policy brief. RD Action, 2018. Available from http://www.rd-action.eu/wp-content/uploads/2018/09/PATIENT-EMPOWERMENT.pdf (accessed 13 October 2022).
- Ali SR, Bryce J, Tan LE, et al. The EuRRECa Project as a model for data access and governance policies for rare disease registries that collect clinical outcomes. Int J Environ Res Public Health 2020; 17(23): 8743. doi: 10.3390/ijerph17238743.
- Richesson R, Vehik K. Patient registries: utility, validity and inference. Adv Exp Med Biol 2010; 686: 87–104. doi: 10.1007/978-90-481-9485-8_6.
- Sernadela P, González-Castro L, Carta C, et al. Linked registries: connecting rare disease patient registries through a semantic web layer. Biomed Research Int 2017; 2017:8327980. doi: 10.1155/2017/8327980.
- Opladen T, Gleich F, Kozich V, et al. U-IMD: the first Unified European registry for inherited metabolic diseases. Orphanet J Rare Dis 2021; 16: 95 (2021). doi: 10.1186/s13023-021-01726-3.
- Ali SR, Bryce J, Smythe C, et al. Supporting international networks through platforms for standardised data collection – the European Registries for Rare Endocrine Conditions (EuRRECa) model. Endocrine 2021; 71(3): 555–560. doi: 10.1007/s12020-021-02617-0.
- Kodra Y, Weinbach J, Posada-de-la-Paz M, et al. Recommendations for improving the quality of rare disease registries. Int J Environ Res Public Health 2018; 15(8): 1644. doi: 10.3390/ijerph15081644.
- Pipe S, Reddy KR, Chowdary P. Gene therapy: Practical aspects of implementation. Haemophilia 2022; 28 (Suppl 4): 44–52. doi: 10.1111/hae.14545.
- Miesbach W, Chowdhary P, Coppens M, et al. Delivery of AAV-based gene therapy through haemophilia centres – A need for re-evaluation of infrastructure and comprehensive care: A joint publication of EAHAD and EHC. Haemophilia 2021; 27(6): 967–973. doi: 10.1111/hae.14420.
- Kaliyaperumal R, Wilkinson MD, Moreno PA, et al. Semantic modelling of common data elements for rare disease registries, and a prototype workflow for their deployment over registry data. J Biomed Semant 2022; 13: 9 (2022). doi: 10.1186/s13326-022-00264-6.
- Health RI. Personal Health Train. Available from https://www.health-ri.nl/initiatives/personal-health-train (accessed 18 October 2022).
- van Soest J, Sun C, Mussmann O, et al. Using the Personal Health Train for automated privacy-preserving analytics on vertically partitioned data. Stud Health Technol Inform 2018; 247: 581–585.
- EAHAD. European Haemophilia Centres Certification. Available from https://eahad.org/european-haemophilia-centres-certification/ (accessed 18 October 2022).
- Maskrey N. Shared understanding with patients. JAMA Intern Med 2017; 177(9): 1247–1248. doi: 10.1001/jamainternmed.2017.1932.
- Nossair F, Thornburg C. The role of patient and healthcare professional in the era of new hemophilia treatments in developed and developing countries. Ther Adv Hematol 2018; 9(8): 239–249. doi: 10.1177/2040620718784830.
- Bahlman-can Ooijen W, van Belle E, Bank A, et al. Nursing leadership to facilitate patient participation in fundamental care: an ethnographic qualitative study. J Adv Nurs 2022; Jun 24. doi: 10.1111/jan.15329. Online ahead of print.
- Konkle BA, Coffin D, Pierce GF, et al. World Federation of Hemophilia Gene Therapy Registry. Haemophilia 2020; 26(4): 563–564. doi: 10.1111/hae.14015.
- Konkle B, Pierce G, Coffin D, et al. Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH. J Thromb Haemost 2020; 18(11): 3074–3077. doi: 10.1111/jth.15023.
- Konkle BA, Recht M, Hilger A, Marks P. The critical need for postmarketing surveillance in gene therapy for haemophilia. Haemophilia 2021; 27(Suppl 3): 126–131. doi: 10.1111/hae.13972.
- Monaco L, Faccio L. Patient-driven search for rare disease therapies: the Fondazione Telethon success story and the strategy leading to Strimvelis. EMBO Mol Med 2017; 9(3): 289–292. doi: 10.15252/emmm.201607293.
- EHC. Think Tank. Available from https://ehcthinktank.eu (accessed 6 January 2023).
- Chatham House. Chatham House rule. Available from https://www.chathamhouse.org/about-us/chatham-house-rule (accessed 6 January 2023).